Pharmaceuticals

A new study suggests the drug’s influence over our brain’s control systems may attenuate behaviors linked to aggression, which, given the widespread use of these pharmaceuticals, could ultimately dampen the rate of violent crime.

For decades, successfully targeting the central mechanism that causes the vast majority of pancreatic cancers was considered impossible. However, that narrative is rapidly changing ...

Millions of Americans can now look forward to a better time traveling, with the US Food and Drug Administration approving a novel oral pill that helps prevent motion-induced vomiting – the first of its kind in more than 40 years.

An antiviral targeting the dengue virus was quietly abandoned by industry, but it's now suddenly back in the spotlight. A new study suggests it didn’t just slow the dengue virus, it blocked viral replication and reduced infection rates at high doses.

A new oral drug may become the first prescription pill specifically designed to regrow hair in both women and men – and without the cardiac risks. Currently in Phase 3 trials, it could be the first new treatment for pattern hair loss in nearly 30 years

A new drug candidate could become a first-in-class medication, after impressive results in a mid-stage clinical trial for drug-resistant epilepsy. It now moves to Phase 3 trials, raising hope for people who suffer seizures despite being on medication.

What if you could inject a drug into a "problem area" – like the abdomen – and have it safely and rapidly kill off fat cells? We could be within 12 months of this reality, as the world's first safe, targeted fat-loss jab enters Phase 3 trials.

A once-a-week Parkinson’s injection could replace multiple daily pills, thanks to a new slow-release formulation developed by researchers. It promises easier treatment, fewer missed doses, and better symptom control.

For some common medical conditions, timing is everything when it comes to taking medications. Now, a customizable capsule engineered at UC San Diego could simplify complicated dosing schedules thanks to a unique staged release system.

The US Food and Drug Administration has approved the use of a novel painkiller for short-term moderate-to-severe pain in adults. It’s the first of a new class of analgesics to be approved in over 20 years - and, importantly, isn't addictive.